Predictive utility of systemic inflammatory markers in differentiating laryngeal lesions
Open Access
- 8 July 2025
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (12) , 6591-6598
Abstract
Purpose: Laryngeal lesions encompass both benign and malignant pathologies and present with symptoms ranging from hoarseness to throat pain. This study aimed to evaluate the predictive value of systemic inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammatory index (SII), systemic inflammatory response index (SIRI) and haemoglobin-albumin-lymphocyte-platelet (HALP) score, for distinguishing malignant from benign laryngeal lesions. Study design: Single-center retrospective cross-sectional analysis. Setting: Tertiary medical institution. Methods: This single-centre retrospective cross-sectional study analysed 442 patients presenting with hoarseness at a tertiary centre between 2020 and 2023. Based on their biopsy results, the patients were classified into four groups: benign lesions, low-grade dysplasia, high-grade dysplasia, and squamous cell carcinoma (SCC). Preoperative blood tests were used to calculate inflammatory markers. Statistical analyses included Kruskal–Wallis tests and post-hoc pairwise comparisons, with significance set at p < 0.05. Results: The SCC group demonstrated significantly higher median NLR, SII and SIRI values and lower LMR and HALP scores than the benign and dysplastic groups ( p < 0.001). Among the indices, SIRI exhibited the highest predictive accuracy for SCC, with an AUC of 0.7, followed by NLR (0.681) and SII (0.672). HALP showed predictive value but was significant only between SCC and benign lesions. Multivariate logistic regression identified SII and LMR as predictive factors. Conclusion: Systemic inflammatory markers, particularly SIRI, SII and LMR, hold promise as adjunctive diagnostic tools for assessing malignancy risk in laryngeal lesions. Although their standalone prognostic utility remains limited, these indices may improve clinical decision-making by identifying high-risk patients for earlier biopsy appointments.Keywords
Funding Information
- Balikesir University
This publication has 22 references indexed in Scilit:
- Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakiaEuropean Archives of Oto-Rhino-Laryngology, 2019
- Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical CancerScientific Reports, 2019
- The effects of smoking on neutrophil/lymphocyte, platelet//lymphocyte ratiosBratislava Medical Journal, 2018
- Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysisOncotarget, 2017
- Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic reviewOncotarget, 2017
- Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinibOncotarget, 2016
- The correlation between the metabolic tumor volume and hematological parameters in patients with esophageal cancerAnnals of Nuclear Medicine, 2015
- Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis.2015
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research, 2014
- Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate CancerClinical Genitourinary Cancer, 2014